Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Reversing female hair loss.

The document discusses how to identify and manage common skin conditions in children.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Some psychiatric drugs can cause skin problems, but serious reactions are rare.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Semaglutide may help some skin disorders but can also cause skin issues.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.